Governance at Scale: How Health Plans Can Risk-Tier LLMs

Governance at Scale

As artificial intelligence reshapes healthcare operations—from member outreach to risk adjustment—health plans face a pivotal question: how to harness large language models (LLMs) safely and strategically. The answer lies in robust governance that tiers each model based on its capacity, accuracy, bias risk, and regulatory exposure.

The Landscape: Capabilities Without Guarantees

Large language models have emerged as versatile tools capable of generating fluent, contextually rich content and responding to queries across a wide spectrum of domains. Some models excel in conversational fluency, while others focus on delivering traceable, source-backed answers. However, fluency and technical metrics like perplexity—which measure how well a model predicts the next word in a sequence—do not guarantee factual reliability, safety, or fairness.

While these models demonstrate strong baseline performance, they can generate incomplete, outdated, or hallucinated content. A 2023 Stanford study found that some models hallucinated in over 20% of healthcare-related outputs, particularly when asked to summarize or recommend treatments¹. These shortcomings make rigorous evaluation and governance essential when applying LLMs in healthcare, where the stakes include patient safety, regulatory compliance, and operational integrity.

Strengths and Limitations in a Healthcare Setting

Clinical studies and operational evaluations suggest that general-purpose LLMs show promising results in areas like patient communication, decision support, and knowledge synthesis. However, assessments also reveal inconsistencies in accuracy, response variability, and hallucination of data or references. A Mayo Clinic review found that only 59% of model-generated clinical advice aligned with actual medical guidelines when left unchecked². Models often struggle with nuance in medical context or decision-making logic, and may underperform in real-world clinical alignment.

These limitations reinforce a critical truth: even the most sophisticated LLMs must be carefully validated and monitored, particularly when integrated into healthcare workflows that impact diagnoses, treatments, or member experiences.

A Regulatory Horizon: LLMs as High-Risk Medical Tools

Governance is becoming non-negotiable. The FDA’s AI/ML Action Plan calls for lifecycle monitoring, model versioning, and real-world performance auditing. The European Union’s AI Act classifies healthcare-related AI as "high-risk," and evolving HIPAA interpretations increasingly cover algorithmic transparency and data traceability.

A Deloitte report from 2023 found that 71% of healthcare executives believe AI regulations will significantly affect future digital strategies, particularly around LLM use³. For health plans, this means implementing a rigorous framework that risk-tiers LLMs based on their application, capability, and potential for harm.

A Four-Tier Risk Framework for Health Plan LLMs

Mizzeto proposes a structured tiering model aligned with payer priorities in compliance, automation, and member impact.

Tier 1: Advisory or Information Retrieval

Tier 1 includes models used for non-clinical functions such as internal knowledge bases, FAQ bots, and general education. These applications typically present minimal risk, as they do not influence care decisions or involve sensitive data handling. The primary concerns here are outdated content and potential inaccuracies, which can usually be mitigated with well-defined content review cycles.

Governance strategies at this level should focus on basic controls: logging user interactions, conducting periodic accuracy audits, and performing Privacy Impact Checks (PICs) to ensure no protected health information (PHI) is inadvertently introduced. These models are well suited for provider self-service portals, employee onboarding, and low-risk internal search applications.

Tier 2: Administrative Automation

Tier 2 applies to models assisting with operational workflows such as claims triage, prior authorization support, and provider communications. These models play a more active role in administrative decision-making, which introduces a higher risk of downstream impact. Errors at this level could lead to incorrect approvals, delays in processing, or provider dissatisfaction.

Due to this elevated risk, governance must include human-in-the-loop oversight for high-stakes outputs. Logs should capture both prompts and model responses, and performance monitoring should track error rates, bias, and hallucination frequency. Following NIST-aligned frameworks, health plans should incorporate calibration tests to measure overconfidence in outputs and reduce automation bias.

Tier 3: Clinical-Support Applications

This tier includes use cases that directly assist clinical staff or members in understanding care options, interpreting medical information, or identifying risk factors. These models often influence—but do not finalize—care decisions. Because they operate in a high-stakes domain, even small inaccuracies or biases can disproportionately affect health outcomes or erode trust.

Effective governance in Tier 3 requires multiple layers of human review, ideally involving clinicians who can assess content accuracy and relevance. Models should be stress-tested using adversarial techniques to detect vulnerabilities such as data poisoning or performance degradation over time. Additionally, governance must track model provenance, enforce version control, and implement audit trails aligned with FDA and NIST guidelines.

Tier 4: Regulated Diagnostic or Therapeutic Support

The highest tier is reserved for models that directly assist with diagnosis, treatment planning, or other regulated medical functions. These systems are considered Software as a Medical Device (SaMD) and must comply with FDA clearance pathways, such as 510(k) or De Novo classifications. They are subject to the highest scrutiny due to their potential to directly impact patient care.

Governance in Tier 4 must be rigorous and comprehensive. This includes validated performance benchmarks, adherence to GxP practices, explainability standards, and the ability to override model recommendations in real time. These systems also require continuous real-world monitoring to ensure safety and effectiveness, as well as extensive bias testing to ensure equitable performance across diverse populations. Only models that have met these stringent requirements should be deployed in high-impact diagnostic or therapeutic environments.

Why Tiering Matters for Health Plans

A tiered governance model offers multiple strategic advantages. It enables fast rollout of low-risk tools while dedicating due diligence to high-risk applications. It ensures compliance with regulatory bodies like the FDA and aligns with global standards such as the EU AI Act. Most importantly, it focuses oversight where it matters most—on applications where errors can cause harm.

Health plans can operationalize this framework by cataloging LLM use cases and mapping them to the appropriate tier. Governance committees—spanning compliance, clinical, and IT—can establish playbooks, monitoring protocols, and update cadences. Dashboards tracking hallucination rates, bias drift, and PHI leakage support transparency and continuous improvement. This governance strategy dovetails with Mizzeto’s core philosophy: Protect People, Prioritize Equity, and Promote Health Value.

Additionally, implementing this model encourages a culture of responsible innovation. It gives organizations a structured way to experiment with new LLM applications while minimizing exposure to risk. Teams across legal, compliance, product, and data science can speak a common governance language, ensuring that development velocity doesn’t outpace safety and trust requirements.

Mizzeto has already begun implementing this governance model at scale for a Fortune 500 healthcare company, supporting LLM deployment across multiple departments including claims operations, care coordination, and digital member services. By embedding tiered oversight into AI adoption, Mizzeto has helped this client reduce operational risk, meet regulatory expectations, and confidently scale their use of generative AI while keeping patient safety and data integrity at the forefront.

The Road Ahead

As LLM adoption accelerates, governance frameworks must evolve. Explainable AI is essential for clinician trust. Bias detection mechanisms are critical for fair outcomes. Guardrails against data poisoning and alignment with NIST/WHO guidelines will future-proof these systems.

Notably, a McKinsey report found that 60% of healthcare leaders plan to expand generative AI initiatives in 2024, but only 21% have implemented formal governance structures to manage associated risks⁴. These gaps underscore the need for structured oversight like the tiering approach outlined here.

Health plans are at a turning point. Poorly governed AI can result in clinical missteps, regulatory fines, or reputational harm. Smart governance, on the other hand, transforms risk into strategic advantage. By stratifying LLMs into risk-aligned tiers, Mizzeto empowers health plans to deploy AI responsibly, drive innovation, and safeguard patient trust. Governance isn’t just compliance—it’s the infrastructure for sustainable, scalable AI success in healthcare.

If your organization is navigating the complexities of LLM deployment and seeking a structured, proven approach to governance, Mizzeto is here to help. With deep experience implementing tiered risk models for Fortune 500 healthcare clients, we understand how to balance innovation with compliance, safety, and ROI. Whether you're exploring administrative use cases or deploying LLMs in clinical environments, our team can guide you through every step of responsible integration. Please reach out to Mizzeto to learn how we can help you properly risk-tier your LLMs and deploy them with confidence.

‍

¹AI on Trial: Legal Models Hallucinate in 1 out of 6 (or More) Benchmarking Queries

²Medical Hallucinations in Foundation Models and Their Impact on Healthcare

³About 40% of health execs say generative AI pays off, Deloitte finds

⁴Generative AI in healthcare: Current trends and future outlook

AI Data Governance

The rapid acceleration of AI in healthcare has created an unprecedented challenge for payers. Many healthcare organizations are uncertain about how to deploy AI technologies effectively, often fearing unintended ripple effects across their ecosystems. Recognizing this, Mizzeto recently collaborated with a Fortune 25 payer to design comprehensive AI data governance frameworks—helping streamline internal systems and guide third-party vendor selection.

This urgency is backed by industry trends. According to a survey by Define Ventures, over 50% of health plan and health system executives identify AI as an immediate priority, and 73% have already established governance committees.

*Define Ventures, Payer and Provider Vision for AI Survey*

However, many healthcare organizations struggle to establish clear ownership and accountability for their AI initiatives. Think about it, with different departments implementing AI solutions independently and without coordination, organizations are fragmented and leave themselves open to data breaches, compliance risks, and massive regulatory fines.

Principles of AI Data Governance

AI Data Governance in healthcare, at its core, is a structured approach to managing how AI systems interact with sensitive data, ensuring these powerful tools operate within regulatory boundaries while delivering value.

For payers wrestling with multiple AI implementations across claims processing, member services, and provider data management, proper governance provides the guardrails needed to safely deploy AI. Without it, organizations risk not only regulatory exposure but also the potential for PHI data leakage—leading to hefty fines, reputational damage, and a loss of trust that can take years to rebuild.

Healthcare AI Governance can be boiled down into 3 key principles:

Protect People – Ensuring member data privacy, security, and regulatory compliance (HIPAA, GDPR, etc.).

Prioritize Equity – Mitigating algorithmic bias and ensuring AI models serve diverse populations fairly.

Promote Health Value - Aligning AI-driven decisions with better member outcomes and cost efficiencies.

Protect People – Safeguarding Member Data

For payers, protecting member data isn’t just about ticking compliance boxes—it’s about earning trust, keeping it, and staying ahead of costly breaches. When AI systems handle Protected Health Information (PHI), security needs to be baked into every layer, leaving no room for gaps.

To start, payers can double down on essentials like end-to-end encryption and role-based access controls (RBAC) to keep unauthorized users at bay. But that’s just the foundation. Real-time anomaly detection and automated audit logs are game-changers, flagging suspicious access patterns before they spiral into full-blown breaches. Meanwhile, differential privacy techniques ensure AI models generate valuable insights without ever exposing individual member identities.

Enter risk tiering—a strategy that categorizes data based on its sensitivity and potential fallout if compromised. This laser-focused approach allows payers to channel their security efforts where they’ll have the biggest impact, tightening defenses where it matters most.

On top of that, data minimization strategies work to reduce unnecessary PHI usage, and automated consent management tools put members in the driver’s seat, letting them control how their data is used in AI-powered processes. Without these layers of protection, payers risk not only regulatory crackdowns but also a devastating hit to their reputation—and worse, a loss of member trust they may never recover.

Prioritize Equity – Building Fair and Unbiased AI Models

AI should break down barriers to care, not build new ones. Yet, biased datasets can quietly drive inequities in claims processing, prior authorizations, and risk stratification, leaving certain member groups at a disadvantage. To address this, payers must start with diverse, representative datasets and implement bias detection algorithms that monitor outcomes across all demographics. Synthetic data augmentation can fill demographic gaps, while explainable AI (XAI) tools ensure transparency by showing how decisions are made.

But technology alone isn’t enough. AI Ethics Committees should oversee model development to ensure fairness is embedded from day one. Adversarial testing—where diverse teams push AI systems to their limits—can uncover hidden biases before they become systemic issues. By prioritizing equity, payers can transform AI from a potential liability into a force for inclusion, ensuring decisions support all members fairly. This approach doesn’t just reduce compliance risks—it strengthens trust, improves engagement, and reaffirms the commitment to accessible care for everyone.

Promote Health Value – Aligning AI with Better Member Outcomes

AI should go beyond automating workflows—it should reshape healthcare by improving outcomes and optimizing costs. To achieve this, payers must integrate real-time clinical data feeds into AI models, ensuring decisions account for current member needs rather than outdated claims data. Furthermore, predictive analytics can identify at-risk members earlier, paving the way for proactive interventions that enhance health and reduce expenses.

Equally important are closed-loop feedback systems, which validate AI recommendations against real-world results, continuously refining accuracy and effectiveness. At the same time, FHIR-based interoperability enables AI to seamlessly access EHR and provider data, offering a more comprehensive view of member health.

To measure the full impact, payers need robust dashboards tracking key metrics such as cost savings, operational efficiency, and member outcomes. When implemented thoughtfully, AI becomes much more than a tool for automation—it transforms into a driver of personalized, smarter, and more transparent care.

Integrated artificial intelligence compliance — FTI Technology

‍

Importance of an AI Governance Committee

An AI Governance Committee is a necessity for payers focused on deploying AI technologies in their organization. As artificial intelligence becomes embedded in critical functions like claims adjudication, prior authorizations, and member engagement, its influence touches nearly every corner of the organization. Without a central body to oversee these efforts, payers risk a patchwork of disconnected AI initiatives, where decisions made in one department can have unintended ripple effects across others. The stakes are high: fragmented implementation doesn’t just open the door to compliance violations—it undermines member trust, operational efficiency, and the very purpose of deploying AI in healthcare.

To be effective, the committee must bring together expertise from across the organization. Compliance officers ensure alignment with HIPAA and other regulations, while IT and data leaders manage technical integration and security. Clinical and operational stakeholders ensure AI supports better member outcomes, and legal advisors address regulatory risks and vendor agreements. This collective expertise serves as a compass, helping payers harness AI’s transformative potential while protecting their broader healthcare ecosystem.

Mizzeto’s Collaboration with a Fortune 25 Payer

At Mizzeto, we’ve partnered with a Fortune 25 payer to design and implement advanced AI Data Governance frameworks, addressing both internal systems and third-party vendor selection. Throughout this journey, we’ve found that the key to unlocking the full potential of AI lies in three core principles: Protect People, Prioritize Equity, and Promote Health Value. These principles aren’t just aspirational—they’re the bedrock for creating impactful AI solutions while maintaining the trust of your members.

If your organization is looking to harness the power of AI while ensuring safety, compliance, and meaningful results, let’s connect. At Mizzeto, we’re committed to helping payers navigate the complexities of AI with smarter, safer, and more transformative strategies. Reach out today to see how we can support your journey.

If you're a VP of Configuration, CIO, or COO at a mid-size health plan, you've likely heard the horror stories. A health plan system migration that was supposed to modernize operations instead creates months of claims backlogs. Provider networks revolt over payment delays. Members flood call centers with complaints. The project that promised transformation becomes a fight for survival.

These cautionary tales aren't outliers. According to research from McKinsey and the University of Oxford, large-scale IT projects run an average of 45 percent over budget and 7 percent over time, while delivering 56 percent less value than predicted (McKinsey, 2012). In healthcare specifically, Gartner research indicates that 83 percent of data migration projects either fail outright or don't meet their planned budgets and schedules (Gartner, 2023). For health plans managing complex claims systems like QNXT or Facets, these statistics should be a wake-up call.

The Real Cost of Getting It Wrong

When a health plan system migration fails, the consequences ripple across every corner of your organization. Claims processing grinds to a halt, creating backlogs that can take months to clear. Providers lose confidence when payments are delayed or adjudicated incorrectly, straining relationships you've spent years building. Members experience frustration when their claims are denied in error or their benefits information is inaccessible.

Perhaps most critically, regulatory compliance can be compromised during a troubled migration. With the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) requiring impacted payers to implement non-technical provisions by January 1, 2026, and API requirements by January 1, 2027, the margin for error has never been thinner (CMS, 2024). A botched migration can put your organization at risk of failing to meet these mandates, potentially exposing you to penalties and damaging your reputation with state regulators.

McKinsey's research reveals an even more sobering reality: 17 percent of large IT projects become "black swans"—catastrophic failures with budget overruns exceeding 200 percent that can threaten the very existence of the organization (McKinsey, 2012). For a regional Medicaid MCO or Medicare Advantage plan operating on thin margins, a project of this magnitude going wrong isn't just an inconvenience. It's an existential threat.

What Success Actually Looks Like in a Health Plan System Migration

Too many health plans define migration success narrowly as reaching go-live. But true success extends far beyond flipping the switch. A successful health plan system migration delivers operational stability from day one. Claims auto-adjudication rates remain high. Provider payment cycles stay consistent. Member services teams can access accurate information to resolve inquiries.

Configuration accuracy is equally essential. Your benefit plans, provider contracts, and business rules must translate precisely from the legacy system to the new platform. Even minor configuration errors can cascade into major payment inaccuracies, triggering provider disputes and regulatory scrutiny. According to KLAS Research, network and provider contracts are among the biggest challenges to manage in any claims processing platform, and misconfigurations during migration are a primary source of post-go-live problems (KLAS, 2020).

Staff adoption matters just as much as technical execution. The most elegantly designed system delivers no value if your configuration analysts, claims examiners, and customer service representatives can't use it effectively. Success means your teams feel confident, not overwhelmed, when they log in on day one. Finally, regulatory compliance must be maintained throughout the transition. Whether it's HIPAA data security, state-specific Medicaid requirements, or the looming CMS interoperability mandates, your compliance posture can never take a back seat to project timelines.

Key Phases of a Successful Migration

The foundation of any successful migration is a thorough discovery and assessment phase. This isn't a cursory inventory of your current system—it's a deep dive into how your organization actually operates. Which benefit configurations are standard, and which represent years of accumulated customizations? What undocumented workarounds has your team developed? Where does institutional knowledge live that might not survive the transition? Rushing through discovery virtually guarantees costly surprises later.

Parallel testing is where theory meets reality. Running both systems simultaneously on real-world claim scenarios exposes discrepancies before they become production problems. This phase requires patience and rigor. A regional health plan that recently migrated from a legacy platform discovered during parallel testing that their provider fee schedule translations had subtle rounding errors. Catching this before go-live prevented what would have been thousands of incorrect payments and the administrative nightmare of recoupment.

Data validation cannot be an afterthought. Member eligibility records, provider demographics, historical claims data, and prior authorization information must transfer accurately and completely. HIMSS Analytics research indicates that 78 percent of healthcare organizations have either completed or are in the process of migrating data to new systems, and data compatibility issues remain a top challenge (HIMSS, 2023). Establishing clear validation protocols and acceptance criteria before migration begins gives your team objective measures of success.

Staff training deserves far more attention than most migration plans allocate. Your configuration analysts need hands-on practice with the new system's logic, not just theoretical walkthroughs. Your claims examiners need to understand how familiar processes translate to new workflows. Change management isn't a soft skill—it's a critical success factor. A phased rollout approach reduces risk by allowing you to identify and address issues at manageable scale. Finally, post-go-live stabilization requires dedicated resources and realistic expectations. Even well-executed migrations require weeks of close monitoring and rapid issue resolution.

Common Pitfalls to Avoid

The most dangerous pitfall is underestimating configuration complexity. Health plan configurations are living systems shaped by years of regulatory changes, contract negotiations, and operational refinements. What appears straightforward in documentation often conceals intricate dependencies. Plans that approach migration as a simple lift-and-shift inevitably discover—usually too late—that their new system doesn't behave as expected.

Insufficient user acceptance testing is equally perilous. Under pressure to meet deadlines, organizations often truncate UAT cycles or limit testing to sunny-day scenarios. But edge cases and exception handling are where migrations most frequently fail. The claim that adjudicates perfectly in testing may error when it encounters an unusual modifier combination or a retroactive eligibility change. Comprehensive UAT requires time, realistic test data, and involvement from the staff who will actually use the system.

Inadequate change management rounds out the most common failure modes. Technical excellence means nothing if your organization isn't prepared to adopt new ways of working. Resistance from staff who feel blindsided or unsupported can undermine even the best implementations. The Standish Group's CHAOS Report consistently identifies lack of executive support and user involvement as primary drivers of project failure (Standish Group, 2020).

The Role of Experienced Partners

Health plan system migrations are not the time for on-the-job learning. The complexity of claims configurations, the stakes of regulatory compliance, and the operational risks involved demand expertise that comes from hands-on experience across multiple implementations. Partners who have configured QNXT, Facets, or other major platforms bring pattern recognition that internal teams simply cannot develop from a single migration.

Specialized consultants can identify configuration pitfalls before they become problems, validate data migration completeness, and provide the supplemental staffing that allows your core team to maintain operational continuity during the transition. They bring objectivity to project planning, helping executives set realistic timelines and budgets based on actual experience rather than optimistic projections. For mid-size health plans without dedicated implementation teams, external expertise isn't a luxury—it's often the difference between success and costly failure.

Modernization as Competitive Advantage

The health plans that navigate system migrations successfully don't just survive—they emerge stronger. Modern core administration platforms enable the operational agility that today's healthcare environment demands. They position organizations to meet CMS interoperability requirements not as a compliance burden but as an opportunity to improve member and provider experiences. They create the foundation for AI-powered automation, real-time analytics, and the kind of operational efficiency that translates directly to competitive advantage.

The question isn't whether your health plan will eventually need to modernize its systems. The question is whether you'll do it on your terms, with careful planning and expert support, or be forced into a reactive scramble when legacy platforms can no longer keep pace with regulatory and market demands.

Partner with Mizzeto for Your System Migration

At Mizzeto Healthcare Technology Consulting, we specialize in helping mid-size health plans navigate the complexities of system migrations. Our consultants bring deep, hands-on experience with QNXT, Facets, and other leading claims platforms. We understand the configuration intricacies that can derail a migration, the regulatory requirements that can't be compromised, and the operational realities of keeping a health plan running while transforming its technology foundation.

Whether you're planning a migration to meet CMS 2026 mandates, evaluating new core administration platforms, or recovering from a troubled implementation, Mizzeto can help. We offer migration readiness assessments, configuration validation, staff augmentation, and the specialized expertise that turns high-risk projects into successful transformations.

Contact Mizzeto today for a free migration readiness assessment. Let's discuss how we can help your health plan modernize with confidence.

‍

References

CMS. (2024). CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F). Centers for Medicare & Medicaid Services. https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f

Gartner. (2023). Data Migration Project Failure Statistics. Referenced in Barcelona Health Hub analysis.

HIMSS Analytics. (2023). Healthcare Data Migration Survey Report.

KLAS Research. (2020). Payer Core Administration Platforms: New Decisions and New Life. https://klasresearch.com/report/payer-core-administration-platforms-2020

McKinsey & Company. (2012). Delivering Large-Scale IT Projects on Time, on Budget, and on Value. McKinsey Digital.

Standish Group. (2020). CHAOS Report: Beyond Infinity. The Standish Group International.

‍

Few initiatives test a health plan's operational resilience like a core claims system implementation. According to research from McKinsey and the University of Oxford, 66% of enterprise software projects experience cost overruns, and 17% go so badly they threaten the organization's existence.^¹ For health plans implementing QNXT, the stakes include regulatory compliance, provider relationships, and member satisfaction—all at risk if the project goes sideways.

The good news: most implementation failures are preventable. Understanding where projects typically break down allows health plans to plan proactively and avoid the most common pitfalls.

Data Migration and Conversion Complexity

Every QNXT implementation begins with a deceptively simple question: how do we move our data? The answer is never straightforward. Legacy claims systems store member information, provider records, and historical claims in formats that rarely align with QNXT's data model. Mapping decades of accumulated data—complete with inconsistencies, duplicates, and outdated codes—requires meticulous planning.

The risks are significant. Incomplete member histories create gaps in care coordination. Misaligned provider data leads to incorrect reimbursements. Claims history errors trigger audit findings and compliance exposure.

What works: Successful migrations follow a phased approach. Extract and profile legacy data early to understand its quality and structure. Build robust mapping rules with input from both technical staff and business users who understand the data's context. Validate extensively in parallel testing environments before cutover—identifying discrepancies in a test environment costs far less than fixing them in production. Budget adequate time for data cleansing; it almost always takes longer than planned.

Benefit Configuration Complexity

QNXT's flexibility is both its greatest strength and its most significant implementation hurdle. Configuring benefits correctly requires understanding the interplay between plan-level and product-level settings, accumulator logic, coordination of benefits rules, and state-specific requirements for Medicaid and Medicare Advantage populations.

Configuration errors rarely surface immediately. They emerge weeks or months later as claims adjudicate incorrectly, members receive wrong explanations of benefits, or accumulators fail to track properly toward deductibles and out-of-pocket maximums. By then, the remediation effort compounds exponentially.

What works: Prioritize your highest-volume, highest-risk benefit configurations for early testing. Build comprehensive test case libraries that cover edge cases—not just the happy path. Document configuration decisions as you make them; institutional knowledge disappears quickly when team members move on. Engage business analysts who understand both the regulatory requirements and QNXT's configuration nuances. For Medicaid and Medicare Advantage plans, involve compliance staff early to ensure configurations align with CMS requirements.

Auto-Adjudication Rate Optimization

Go-live is just the beginning. Many health plans discover that their auto-adjudication rates plummet after implementing QNXT. The industry standard benchmark for auto-adjudication hovers around 80%, with best practice targets above 85%.^² Yet many organizations fall short, with first-pass rates ranging from 10% to 70%.^³

The financial impact is substantial. An auto-adjudicated claim costs health insurers cents on the dollar, while one requiring human intervention costs approximately $20.^⁴ Every claim that falls out of auto-adjudication strains examiner capacity and extends turnaround times.

Low auto-adjudication rates typically stem from a few root causes: overly conservative editing rules, incomplete provider data, poorly configured fee schedules, or business rules that don't account for real-world claim variations. The system works as configured—the configuration simply doesn't reflect operational reality.

What works: Analyze pend patterns weekly in the months following go-live. Identify which edits generate the most fallout and assess whether they're truly necessary or just overly cautious defaults. Tune provider matching logic to reduce false pends from minor data discrepancies. Refine authorization integration so valid authorizations are properly recognized. Establish a continuous improvement cycle rather than treating go-live as the finish line.

Integration with Your Existing Ecosystem

QNXT doesn't operate in isolation. It must connect with EDI gateways for 837, 835, 834, and 270/271 transactions. It needs interfaces to provider portals, member platforms, care management systems, and payment integrity vendors. Each integration point introduces complexity—and potential failure modes.

The challenge intensifies when health plans operate hybrid environments during transition periods. Data must flow correctly between legacy and new systems without duplication, loss, or timing mismatches. Real-time authorization lookups must perform at production scale. Provider directories must stay synchronized across platforms.

Research shows that 51% of companies experience operational disruptions when going live with new enterprise systems, often due to integration failures.^⁵

What works: Start integration testing earlier than you think necessary. Build end-to-end test scenarios that simulate production volumes and edge cases. Document every interface specification and establish clear ownership for each connection. Consider middleware layers to buffer complexity, but account for the latency and additional failure points they introduce. Plan for a parallel processing period where both old and new systems run simultaneously, allowing you to validate results before fully cutting over.

Training, Change Management, and Staffing Gaps

Even a perfectly configured QNXT instance fails if your people can't use it effectively. Research indicates that up to 75% of the financial benefits from new enterprise systems are directly linked to effective organizational change management—yet many organizations allocate less than 10% of their total project budget to this critical area.^⁶

Implementation partners eventually leave. Institutional knowledge walks out the door. Claims examiners, configuration analysts, and IT staff must internalize new workflows, screens, and processes—often while maintaining production on legacy systems.

The training gap is particularly acute for configuration roles. QNXT benefit configuration requires specialized expertise that takes months to develop. Many health plans underestimate this learning curve and find themselves dependent on external consultants long after go-live.

What works: Build knowledge transfer into implementation contracts from day one. Document configuration decisions and create runbooks for common scenarios. Identify internal staff for intensive mentorship during the project—not just attendance at training sessions, but hands-on involvement in configuration work. Plan for productivity dips in the months following go-live and staff accordingly. Consider whether supplemental staffing can bridge capability gaps during the transition period rather than burning out your core team.

The Five Core QNXT Implementation Challenges

For quick reference, successful QNXT implementations address these critical areas:

Data migration and validation — ensuring complete, accurate conversion from legacy systems through phased extraction, robust mapping, and extensive parallel testing

Benefit configuration — methodical setup with comprehensive testing across all lines of business, with early compliance involvement for government programs

Auto-adjudication optimization — continuous tuning post-go-live to maximize straight-through processing and reduce costly manual intervention

System integration — reliable connections to EDI, portals, and downstream vendors, tested at production scale before cutover

Training and change management — building internal expertise through hands-on involvement, not just classroom training, with realistic productivity expectations

Moving Forward

QNXT implementations are complex, but complexity doesn't have to mean chaos. Health plans that approach these projects with realistic timelines, thorough testing protocols, and genuine investment in their people consistently outperform those who underestimate the effort involved.

The patterns of failure are well-documented. So are the patterns of success. The difference usually comes down to preparation, honest assessment of internal capabilities, and willingness to invest in the areas—like change management and post-go-live optimization—that don't appear on the software license invoice but determine whether the project delivers value.

About Mizzeto

At Mizzeto, we help health plans navigate high-stakes platform transitions with the same rigor they apply to clinical and regulatory decisions. Our teams support QNXT implementations and optimization across Medicare, Medicaid, Exchange, and specialty lines of business—bridging strategy, configuration, and operational execution. The goal isn’t just a successful go-live, but durable performance: higher auto-adjudication, cleaner integrations, and internal teams equipped to govern the system long after consultants exit.

If your organization is preparing for a QNXT implementation—or working to stabilize and optimize one already in production—we’re always open to a thoughtful conversation.

Sources

McKinsey & Company and BT Centre for Major Program Management at the University of Oxford. "Delivering Large-Scale IT Projects On Time, On Budget, and On Value." https://www.forecast.app/blog/66-of-enterprise-software-projects-have-cost-overruns

Healthcare Finance News. "Claims processing is in dire need of improvement, but new approaches are helping." https://www.healthcarefinancenews.com/news/claims-processing-dire-need-improvement-new-approaches-are-helping

HealthCare Information Management. "Understanding Auto Adjudication." https://hcim.com/understanding-auto-adjudication/

Healthcare Finance News. "Claims processing is in dire need of improvement, but new approaches are helping." https://www.healthcarefinancenews.com/news/claims-processing-dire-need-improvement-new-approaches-are-helping

RubinBrown ERP Advisory Services. "Top ERP Insights & Statistics." https://kpcteam.com/kpposts/top-erp-statistics-trends

Sci-Tech-Today. "Enterprise Resource Planning (ERP) Software Statistics." https://www.sci-tech-today.com/stats/enterprise-resource-planning-erp-software-statistics/

‍

Why utilization management may determine who clears the coming audit wave—and who doesn’t.

CMS doesn’t usually announce a philosophical shift. It signals it. And over the past year, the signals have grown louder: tougher scrutiny of utilization management, more rigorous document reviews, and an expectation that payers show—not simply assert—how they operate. The 2026 audit cycle will be the first real test of this new posture.

For health plans, the question is no longer whether they can survive an audit. It’s whether their operations can withstand a level of transparency CMS is poised to demand.

What CMS Is Really Asking for in 2026

Behind every audit protocol lies a single question: Does this plan operate in a way that reliably protects members? Historically, payers could answer that question through narrative explanation—clinical notes, supplemental files, post-hoc clarifications. Those days are ending. CMS wants documentation that stands on its own, without interpretation. Decisions must speak for themselves.

That shift lands hardest in utilization management. A UM case is a dense intersection of clinical judgment, policy interpretation, and regulatory timing. A single inconsistency—a rationale that doesn’t match criteria, a letter that doesn’t reflect the case file, a clock mismanaged by a manual workflow—can overshadow an otherwise correct decision.

The emerging audit philosophy is clear: If the documentation doesn’t prove the decision, CMS assumes the decision cannot be trusted.

Where the System Breaks: UM as the Audit Pressure Point

Auditors are increasingly zeroing in on UM because it sits at the exact point where member impact is felt: the determination of whether care moves forward. And yet the UM environment inside most plans is astonishingly fragile.

Case files exist across platforms. Reviewer notes vary widely in depth and style. Criteria are applied consistently in theory but documented inconsistently in practice. Timeframes live in spreadsheets or side systems. Letter templates multiply to meet state and line-of-business requirements, and each variation introduces new chances for error.

Delegated entities add another degree of variation. AI tools introduce sophistication—but also opacity. And UM letters, already the last mile, turn into the site of the most findings. The audit findings from recent years reveal the same weak points over and over: documentation mismatches, missing citations, unclear rationales, inadequate notice language, or timing failures that stem not from malice but from operational drift.

CMS sees all of this as symptomatic of one problem: fragmentation.

Why CMS’s New Expectations Make Sense—Even If They Hurt

To CMS, consistency is fairness. If two reviewers evaluating the same procedure cannot produce the same rationale, use the same criteria, or generate the same clarity in their letters, then members cannot rely on the decisions they receive. From the regulator’s perspective, this isn’t about paperwork—it’s about equity. Documentation is the proof that similar members receive similar decisions under similar circumstances.

Health plans know this in theory. But the internal pressures—volume, staffing variability, outdated systems, multiple point solutions, off-platform decisions, peer-to-peer nuances—make uniformity nearly impossible. CMS’s response is simple: Technical difficulty is not an excuse. Variation is a governance failure.

This is why the agency is preparing to scrutinize AI tools with the same rigor as human reviewers. Automation that produces variable results, or outputs that do not exactly match the case file, is no different from human inconsistency.

CMS is not anti-AI. It is anti-opaque-AI.

What an Audit-Ready UM Operation Actually Looks Like

Plans that will succeed in 2026 are building something different: a coherent operating system that eliminates guesswork. In these models, the case file becomes a single source of truth. Clinical summaries, criteria references, rationales, and letter text are drawn from the same structured data—so the letter is a natural extension of the decision, not a separate narrative created afterward.

Delegated entities operate under unified templates, shared quality rules, and real-time oversight rather than annual check-ins. AI is governed like a medical policy: with defined behaviour, monitoring, version control, and auditable outputs. And timeframes are treated with claims-like precision, not as deadlines managed by human vigilance.

This is not just modernization—it is a philosophical shift. A move from “reviewers record what happened” to “the system records what is true.”

Preparing for 2026 Starts in 2025

The path forward isn’t mysterious; it’s disciplined. Plans need to invest the next year in cleaning up documentation, consolidating UM data flows, reducing template drift, tightening delegation oversight, and putting governance around every automated tool in the UM pipeline. The plans that do this will walk into audits with confidence. The plans that don’t will rely on explanations CMS is increasingly unwilling to accept.

The Bottom Line

The 2026 CMS audit cycle isn’t a compliance event—it’s an operational reckoning. CMS is asking payers to demonstrate integrity, not describe it. And utilization management will be the proving ground. The strongest plans are already acting. The others will be forced to.

At Mizzeto, we help health plans build the documentation, automation, and governance foundation needed for a world where every UM decision must be instantly explainable. Because in the next audit cycle, clarity isn’t optional—it’s compliance.

‍

In the age of AI-driven utilization management (UM), one paper trail still refuses to move at the speed of automation: the UM letter.

Whether it’s an approval, denial, or request for additional information, these letters remain the last mile of every UM decision, and too often, the slowest. Despite sophisticated review platforms and integrated medical policy engines, many health plans still rely on legacy templates, fragmented data sources, and manual QA loops to generate what regulators consider a fundamental compliance artifact. UM letters are not just a formality; they are a legal requirement. Under CMS rules, plans must issue timely, adequate notice of adverse benefit determinations, explaining both the rationale and appeal rights to members.

The irony is hard to miss: while decisions are made in seconds, the documentation that justifies them can take days.

The Real Question Behind the Delay

The issue isn’t simply that UM letters take time. It’s why they take time, and what that delay reveals about deeper system inefficiencies.

For health plans, the question isn’t “How can we make letters faster?” It’s “Why are they so hard to get right in the first place?”

A single UM letter must synthesize clinical reasoning, regulatory precision, and plain-language clarity all aligned with CMS, NCQA, and state-specific notice requirements. The challenge is not in the writing, but in orchestrating inputs from multiple systems: clinical review notes, policy citations, benefit text, and provider data.

When those inputs don’t talk to each other, letter generation becomes a bottleneck that slows down turnaround times, increases error risk, and erodes member trust.

Why Templates Must Meet More Than Just Style

UM letter templates are not just administrative artifacts; they are regulatory documents. Under Centers for Medicare & Medicaid Services (CMS) rules, letters providing notice of adverse benefit determinations must meet detailed content and timing standards. For example, the regulation at 42 CFR § 438.404 mandates that notices be in writing and explain the reasons for denial, reference the medical necessity criteria or other processes used, provide the enrollee’s rights to copies of evidence and appeal, and outline procedures for expedited review.¹

In practice, this means letter templates must include:

A clear description of the decision and the specific denial reason,

The criteria or protocol relied upon (with member access to it free of charge),

Instructions on how to appeal (standard and expedited),

Rights to benefits continuation pending appeal under defined circumstances.²

Failure to incorporate these elements or to issue the notice within required timeframes can expose plans to audit findings, grievances, and regulatory penalties. The tighter the regulatory lens becomes, the less room there is for “good enough” templates. Each health plan must view letter-generation not as a clerical task but as a compliance checkpoint. And beyond the regulatory content itself, many programs require that UM notices be written in plain, accessible language at the 6^th-8^th grade level, to ensure members can understand their rights and the basis for a decision.

Five Friction Points Inside UM Letter Workflows

Every health plan faces variations of the same problem, but the underlying breakdowns tend to cluster around five recurring fault lines:

Fragmented Data Sources
Critical information lives in multiple systems. UM platforms, claims engines, and policy libraries. Each transfer adds latency and the potential for mismatch.

Template Explosion
Over time, teams accumulate hundreds of letter templates to meet overlapping state and product requirements. Maintaining these manually makes even minor updates a compliance risk.

Human Review Dependency
Because UM letters must be clinically and legally precise, most organizations rely on multiple layers of human QA. That review process, while necessary, often adds 24–48 hours to turnaround.

Regulatory Complexity
CMS and state requirements around adverse determination language, appeal rights, and timing create constant moving targets. Even small wording deviations can trigger audit findings.³

Technology Gaps
Many UM systems weren’t designed for dynamic document assembly. Integrating clinical rationale, structured data, and plain-language output requires middleware or manual intervention.

Each of these friction points compounds the next, creating a cycle of rework, delay, and compliance exposure even in otherwise modernized UM environments.

Connecting the Dots: What the Delay Really Costs

The operational burden of slow UM letters goes far beyond staff productivity. It directly affects regulatory performance, provider satisfaction, and member experience.

Delayed or inconsistent notices can:

Violate CMS and NCQA timeliness standards, exposing plans to corrective action.⁴

Create confusion for providers awaiting determinations, delaying care coordination.

Generate avoidable grievances and appeals, further burdening UM teams.

The cost is not just administrative, it’s reputational. Every late or unclear letter represents a breakdown in transparency at the very point where payers are most visible to members and regulators alike.⁵

Building a Smarter Letter Ecosystem

Leading plans are tackling the problem not with more templates, but with smarter orchestration.

The most effective UM letter modernization strategies share three principles:

Structured Input, Dynamic Output: Capture decision data in structured fields early in the UM process so letters can be assembled automatically with consistent language and logic.

Governance-Driven Templates: Centralize letter libraries under compliance governance, ensuring real-time updates to regulatory text and benefit language.

Human-in-the-Loop Automation: Use AI-assisted generation to draft letters but retain clinical reviewer oversight for rationale and tone.

The goal isn’t to remove people, it’s to remove friction. Automation should serve precision, not replace it.

When designed correctly, next-generation letter systems can cut turnaround time by 50–70%, reduce rework, and strengthen audit readiness while making communications clearer for both providers and members.

The Bottom Line

UM letters may seem administrative, but they are where compliance, communication, and care converge. If denials are the visible output of your UM program, letters are the proof of its integrity.

For payers, the question isn’t whether letters can be automated, it’s whether they can be governed with the same rigor as the decisions they document.

At Mizzeto, we help health plans modernize UM letter workflows, integrating automation, policy governance, and compliance intelligence into one seamless ecosystem.

‍

Governance at Scale: How Health Plans Should Risk-Tier Their LLMs